Biological Assembly 1  

 3D View: Structure | Ligand Interaction

Standalone Viewers  
Protein Workshop | Ligand Explorer

Global Symmetry: Cyclic - C2  (3D View)
Global Stoichiometry: Homo 2-mer - A2 

Biological assembly 1 assigned by authors and generated by PISA (software)

Macromolecule Content

• Total Structure Weight: 22306.41 
• Atom Count: 1564 
• Residue Count: 198 
• Unique protein chains: 1

1YT9

HIV Protease with oximinoarylsulfonamide bound

• DOI: 10.2210/pdb1YT9/pdb

• Classification: HYDROLASE
• Organism(s): Human immunodeficiency virus type 1 group M subtype B
• Expression System: Escherichia coli


• Deposited: 2005-02-10 Released: 2005-04-12 
• Deposition Author(s): Yeung, C.M., Klein, L.L., Flentge, C.A., Randolph, J.T., Zhao, C., Sun, M., Dekhtyar, T., Stoll, V.S., Kempf, D.J.

---

Experimental Data Snapshot

• Method: X-RAY DIFFRACTION
• Resolution: 3 Å
• R-Value Free: 0.338 
• R-Value Work: 0.248 

Literature

Oximinoarylsulfonamides as potent HIV protease inhibitors.

Yeung, C.M., Klein, L.L., Flentge, C.A., Randolph, J.T., Zhao, C., Sun, M., Dekhtyar, T., Stoll, V.S., Kempf, D.J.

(2005) Bioorg.Med.Chem.Lett. 15: 2275-2278

• PubMed: 15837308 
• DOI: 10.1016/j.bmcl.2005.03.008


• PubMed Abstract: 
  

The need for a potent HIV protease inhibitor (PI) to combat emerging PI-resistant viruses is anticipated. Analogs formulated from the combination of structural fragments of Ritonavir, Lopinavir, and Amprenavir were synthesized. Analogs containing the oxime pharmacophore were found to have improved activities against both wild type and resistant (A17) viruses. The synthesis and structure-activity relationships (SAR) based upon the in vitro IC50 of this series of compounds are reported.

---

Organizational Affiliation: 

Abbott Laboratories, GPRD, D-47D, Building AP52N, 200 Abbott Park Road, Abbott Park, IL 60064-3501, USA. [e-mail]

Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
Molecule	Chains	Sequence Length	Organism	Details
Pol polyprotein	A, B	99	Human immunodeficiency virus type 1 group M subtype B	Mutation(s): 0  Gene Names: gag-pol
Find proteins for P03366 (Human immunodeficiency virus type 1 group M subtype B) Go to UniProtKB:  P03366

Small Molecules

Ligands 1 Unique
ID	Chains	Name / Formula / InChI Key	2D Diagram & Interactions
OIS	A	(S)-N-((2S,3R)-3-HYDROXY-4-(4-((E)-(HYDROXYIMINO)METHYL)-N-ISOBUTYLPHENYLSULFONAMIDO)-1-PHENYLBUTAN-2-YL)-3-METHYL-2-(3-((2-METHYLTHIAZOL-4-YL)METHYL)-2-OXOIMIDAZOLIDIN-1-YL)BUTANAMIDE OXIMINOARYLSULFONAMIDE C34 H46 N6 O6 S2 PJLSJXTZOMOVBI-KKWNBLJUSA-N

External Ligand Annotations
ID	Binding Affinity (Sequence Identity %)
OIS	IC50: 5 nM (98) BINDINGDB
OIS	IC50: 5 nM PDBBIND

Experimental Data & Validation

Experimental Data

• Method: X-RAY DIFFRACTION
• Resolution: 3 Å
• R-Value Free: 0.338 
• R-Value Work: 0.248 
• Space Group: P 2₁ 2₁ 2

Unit Cell:

Length (Å)	Angle (°)
a = 58.041	α = 90.00
b = 85.954	β = 90.00
c = 46.033	γ = 90.00

Software Package:

Software Name	Purpose
CNS	phasing
SCALEPACK	data scaling
CNX	refinement
DENZO	data reduction

Structure Validation

Entry History 

Deposition Data

• Deposited Date: 2005-02-10 
• Released Date: 2005-04-12 
• Deposition Author(s): Yeung, C.M., Klein, L.L., Flentge, C.A., Randolph, J.T., Zhao, C., Sun, M., Dekhtyar, T., Stoll, V.S., Kempf, D.J.

Revision History 

• Version 1.0: 2005-04-12
  Type: Initial release
• Version 1.1: 2008-04-30
  Type: Version format compliance
• Version 1.2: 2011-07-13
  Type: Version format compliance